版本:
中国

BRIEF-CanniMed Q1 loss per share C$0.19 from continuing operations

March 16 Cannimed Therapeutics Inc

* Cannimed therapeutics inc. Reports financial results for q1 2017

* Q1 loss per share c$0.19 from continuing operations

* Qtrly sales of $3.4 million were 93% higher than in same period of prior year Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐